TriVascular Technologies IPO Info
Company Name: TriVascular Technologies
Stock Symbol: TRIV
Exchange: NASDAQ
Status: Priced
IPO Date: 4/16/2014
IPO Price:
12.00 (
4.75%)
Underwriters
J.P. Morgan Securities LLC and Credit Suisse Securities (USA) LLC
Amount of Offering: 6,500,000
Number of Shares Offered: N/A
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
TriVascular is a medical device company developing and commercializing innovative technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company manufactures the Ovation Prime Abdominal Stent Graft System, the lowest profile FDA-approved system, which utilizes a novel, polymer-based sealing mechanism. TriVascular is based in Santa Rosa, California.
News Headlines
